Schedule an appointment today
Call to Schedule: 1-866-UH4-CARE
Find Clinical Trials & Studies
Visit the Research & Education Institute

ResQ201A: N-803 Plus TISLELIZUMAB And DOCETAXEL vs DOCETAXEL Monotherapy In NSCLC

Back to Search Results
Share
Facebook
X
Pinterest
LinkedIn
Email
Print
I'm Interested!
Please call
1-866-373-1464

  • Sex: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Therapeutic
  • Trial Phase: Phase I
  • Conditions Being Studied: Cancer - Lung
Principal Investigator
Matthew Mirsky MD
Department/Division
Cancer (Thoracic)
  • UH IRB: STUDY20250608 / Pro00087337
  • StudyID: IMBI1525
  • ClinicalTrials.gov: NCT06745908
I'm Interested!
Please call
1-866-373-1464

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-866-373-1464